| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18622 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-115 |
| filingDate |
2000-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_650c41fee7fbde702f37e1e3745d3f02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f51163f8f5c4200465b7b08adcd9723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e897233f3f0e37b9c84cf39cc8457455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca7adb97af885f83fca017fb3bc37184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcca506c34c21a7792a79e661bbdec4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_320744831f29bd0640b4b278f943c67c |
| publicationDate |
2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7192593-B2 |
| titleOfInvention |
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens |
| abstract |
Chimeric parainfluenza viruses (PIVs) incorporate a PIV vector genome or antigenome and one or more antigenic determinant(s) of a heterologous PIV or non-PIV pathogen. These chimeric viruses are infectious and attenuated in humans and other mammals and are useful in vaccine formulations for eliciting an immune responses against one or more PIVs, or against a PIV and non-PIV pathogen. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric Ply genome or antigenome which includes a partial or complete PIV vector genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) encoding antigenic determinant(s) of a heterologous PIV or non-PIV pathogen. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006099226-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008074749-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11220718-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11273214-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7632508-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023102388-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9803252-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11591372-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9944997-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009081728-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10654898-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022232300-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018222573-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016118642-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011189232-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9834824-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11162148-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10519517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10287640-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10167524-B2 |
| priorityDate |
1997-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |